Rallybio Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rallybio Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
  • Rallybio Corp Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.92M, a 28.9% decline year-over-year.
  • Rallybio Corp Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.19M, a 12.8% decline year-over-year.
  • Rallybio Corp annual Share-based Payment Arrangement, Expense for 2023 was $10.9M, a 15% increase from 2022.
  • Rallybio Corp annual Share-based Payment Arrangement, Expense for 2022 was $9.5M, a 161% increase from 2021.
  • Rallybio Corp annual Share-based Payment Arrangement, Expense for 2021 was $3.65M, a 418% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.19M $1.92M -$777K -28.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $9.96M $2.09M -$957K -31.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.9M $2.55M +$255K +11.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $10.7M $2.63M +$130K +5.19% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $10.5M $2.69M +$45K +1.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $10.5M $3.05M +$991K +48.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $9.5M $2.29M +$765K +50% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $8.73M $2.5M +$1.45M +137% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $7.29M $2.65M +$2.11M +391% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $5.18M $2.05M +$1.53M +293% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.65M $1.53M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 $1.06M +$780K +284% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $539K +$445K +473% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $522K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $275K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $94K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.